We have located links that may give you full text access.
Mortality of Pediatric Surgical Lung Biopsies in Ontario, Canada from 2000-2019.
Annals of the American Thoracic Society 2024 January 24
RATIONALE: Surgical lung biopsies are often required for the definitive diagnosis of non-malignant pediatric diffuse lung diseases, however there is a sparsity of literature on mortality after surgical lung biopsy in pediatric patients.
OBJECTIVES: To determine the 30-day post-operative mortality rate after surgical lung biopsies for non-malignant lung disease in pediatric patients in Ontario, Canada and to identify risk factors associated with mortality.
METHODS: We performed an observational cohort study using population-based health administrative data available from ICES in Ontario, Canada from 2000-2019. Cases were identified using the Canadian Classification of Health Interventions.
INCLUSION CRITERIA: 1) first surgical lung biopsies between 2000-2019, and 2) age <18 years old. Individuals with lung cancer, lung transplant or missing data were excluded. A multivariable logistic regression model, with generalized estimating equation, was used to estimate the 30-day odds of mortality post-surgical lung biopsy and identify patient characteristics associated with increased mortality, while accounting for clustering by hospital.
RESULTS: We identified 1474 pediatric patients who underwent surgical lung biopsy in Ontario between 2000-2019. The overall mortality rates decreased over the study duration from 6.6%(2000-2004) to 3.0%(2015-2019). The study cohort for multi-variate analyses consisted of 1342 patients who had complete data. The pediatric mortality 30-days post-surgical lung biopsy was 5.1% but <1% in elective cases. Risk factors for increased mortality included open surgical lung biopsy (versus video-assisted) [OR 13.13, 95%CI(3.76, 45.87), p<0.001], non-elective procedure [OR 11.74, 95%CI(3.51, 39.27), p<0.001], younger age (<3 months) [OR 6.04, 95%CI(2.40, 15.22), p<0.001] and higher comorbidity score [OR 1.15, 95%CI(1.05, 1.26), p=0.003].
CONCLUSIONS: Pediatric mortality post-surgical lung biopsy is not insignificant, particularly in non-elective procedures. Other important risk factors to consider when pursuing pathologic diagnosis include surgical approach, younger age, and higher comorbidity.
OBJECTIVES: To determine the 30-day post-operative mortality rate after surgical lung biopsies for non-malignant lung disease in pediatric patients in Ontario, Canada and to identify risk factors associated with mortality.
METHODS: We performed an observational cohort study using population-based health administrative data available from ICES in Ontario, Canada from 2000-2019. Cases were identified using the Canadian Classification of Health Interventions.
INCLUSION CRITERIA: 1) first surgical lung biopsies between 2000-2019, and 2) age <18 years old. Individuals with lung cancer, lung transplant or missing data were excluded. A multivariable logistic regression model, with generalized estimating equation, was used to estimate the 30-day odds of mortality post-surgical lung biopsy and identify patient characteristics associated with increased mortality, while accounting for clustering by hospital.
RESULTS: We identified 1474 pediatric patients who underwent surgical lung biopsy in Ontario between 2000-2019. The overall mortality rates decreased over the study duration from 6.6%(2000-2004) to 3.0%(2015-2019). The study cohort for multi-variate analyses consisted of 1342 patients who had complete data. The pediatric mortality 30-days post-surgical lung biopsy was 5.1% but <1% in elective cases. Risk factors for increased mortality included open surgical lung biopsy (versus video-assisted) [OR 13.13, 95%CI(3.76, 45.87), p<0.001], non-elective procedure [OR 11.74, 95%CI(3.51, 39.27), p<0.001], younger age (<3 months) [OR 6.04, 95%CI(2.40, 15.22), p<0.001] and higher comorbidity score [OR 1.15, 95%CI(1.05, 1.26), p=0.003].
CONCLUSIONS: Pediatric mortality post-surgical lung biopsy is not insignificant, particularly in non-elective procedures. Other important risk factors to consider when pursuing pathologic diagnosis include surgical approach, younger age, and higher comorbidity.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Systemic lupus erythematosus.Lancet 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app